Researchers looked at how patients with upper limb issues after a stroke responded to various types of non-invasive brain stimulation (NIBS). This included methods like rTMS, tDCS, and iTBS. The study included a large group of 2,640 participants to see how well these treatments were tolerated over time.
The results showed that about 95% of patients completed the treatment programs. While some specific methods showed slightly different rankings in the data, there was no significant difference in completion rates between the active treatments and the sham (placebo) groups. This suggests that the procedures are generally well-tolerated by patients.
Safety was also a key focus. About 16.4% of participants reported side effects, but these were mostly mild, such as skin tingling or headaches. Only 1.1% of people had to stop treatment due to these issues. Because the evidence for some specific methods comes from only one study, these findings are currently used to help guide future research rather than making definitive claims about one specific method over another.